|
1
|
Ma NQ, Liu LL, Min J, Wang JW, Jiang WF,
Liu Y, Feng YG, Su HC, Feng YM and Zhang HL: The effect of down
regulation of calcineurin Aα by lentiviral vector-mediated RNAi on
the biological behavior of small-cell lung cancer and its bone
metastasis. Clin Exp Metastasis. 28:765–778. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu Y, Zhang Y, Min J, Liu LL, Ma NQ, Feng
YM, Liu D, Wang PZ, Huang DD, Zhuang Y and Zhang HL: Calcineurin
promotes proliferation, migration, and invasion of small cell lung
cancer. Tumour Biol. 31:199–207. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Travis WD, Brambilla E, Noguchi M,
Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ,
Van Schil PE, et al: IInternational association for the study of
lung cancer/american thoracic society/european respiratory society
international multidisciplinary classification of lung
adenocarcinoma. J Thorac Oncol. 6:244–285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mansuet-Lupo A, Bobbio A, Blons H, Becht
E, Ouakrim H, Didelot A, Charpentier MC, Bain S, Marmey B, Bonjour
P, et al: The new histologic classification of lung primary
adenocarcinoma subtypes is a reliable prognostic marker and
identifies tumors with different mutation status: The experience of
a French cohort. Chest. 146:633–643. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen Z, Liu X, Zhao J, Yang H and Teng X:
Correlation of EGFR mutation and histological subtype according to
the IASLC/ATS/ERS classification of lung adenocarcinoma. Int J Clin
Exp Pathol. 7:8039–8045. 2014.PubMed/NCBI
|
|
6
|
Marchetti A, Buttitta F, Pellegrini S,
Chella A, Bertacca G, Filardo A, Tognoni V, Ferreli F, Signorini E,
Angeletti CA and Bevilacqua G: Bronchioloalveolar lung carcinomas:
K-ras mutations are constant events in the mucinous subtype. J
Pathol. 179:254–259. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Travis WD, Brambilla E and Riely GJ: New
pathologic classification of lung cancer: Relevance for clinical
practice and clinical trials. J Clin Oncol. 31:992–1001. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Marchetti A, Buttitta F, Pellegrini S,
Chella A, Bertacca G, Filardo A, Tognoni V, Ferreli F, Signorini E,
Angeletti CA and Bevilacqua G: Bronchioloalveolar lung carcinomas:
K-ras mutations are constant events in the mucinous subtype. J
Pathol. 179:254–259. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nakaoku T, Tsuta K, Ichikawa H, Shiraishi
K, Sakamoto H, Enari M, Furuta K, Shimada Y, Ogiwara H, Watanabe S,
et al: Druggable oncogene fusions in invasive mucinous lung
adenocarcinoma. Clin Cancer Res. 20:3087–3093. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cai D, Li H, Wang R, Li Y, Pan Y, Hu H,
Zhang Y, Gong R, Pan B, Sun Y and Chen H: Comparison of clinical
features, molecular alterations, and prognosis in morphological
subgroups of lung invasive mucinous adenocarcinoma. Onco Targets
Ther. 7:2127–2132. 2014.PubMed/NCBI
|
|
11
|
Goldstraw P: The 7th Edition of TNM in
Lung Cancer: What now? J Thorac Oncol. 4:671–673. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Giroux DJ, Rami-Porta R, Chansky K,
Crowley JJ, Groome PA, Postmus PE, Rusch V, Sculier JP, Shepherd
FA, Sobin L, et al: The IASLC lung cancer staging project: Data
elements for the prospective project. J Thorac Oncol. 4:679–683.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rusch VW, Asamura H, Watanabe H, Giroux
DJ, Rami-Porta R and Goldstraw P: Members of IASLC Staging
Committee: The IASLC lung cancer staging project: a proposal for a
new international lymph node map in the forthcoming seventh edition
of the TNM classification for lung cancer. J Thorac Oncol.
4:568–577. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Higashiyama M, Doi O, Kodama K, Yokouchi H
and Tateishi R: Cystic mucinous adenocarcinoma of the lung. Two
cases of cystic variant of mucus-producing lung adenocarcinoma.
Chest. 101:763–766. 1992. View Article : Google Scholar : PubMed/NCBI
|
